Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth

NCT ID: NCT02224625

Last Updated: 2017-03-09

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

249 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-08-31

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluating the irritation properties of CHG cloth. Some Subjects will also have the product applied to see if they become sensitized to repeated applications.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

For the Irritation Study (30 subjects), patches containing CHG, vehicle, saline, CHG comparator or sodium lauryl sulfate (a product that is expected to produce a slight skin irritation) will be placed on the same spot of your skin every day for 21 days. The skin will be examined every day.

The Sensitization Study (200 total subjects) place patches containing CHG, vehicle, saline, CHG comparator on the skin 3 times a week for 3 weeks. Following a two-week rest period the patches will be reapplied for 48 hours and assessed out to 72 hours thereafter.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2% CHG Cloth

Chlorhexidine Gluconate 2%

Group Type EXPERIMENTAL

2% CHG Cloth solution

Intervention Type DRUG

Investigational CHG

Vehicle Cloth

Excipients on cloth

Group Type PLACEBO_COMPARATOR

Vehicle Cloth

Intervention Type DEVICE

Excipients from CHG cloth only

DynaHex (2% CHG)

Chlorhexidine Gluconate 2% solution

Group Type ACTIVE_COMPARATOR

Active Comparator

Intervention Type DRUG

Active comparator

Saline

0.9% sodium chloride

Group Type SHAM_COMPARATOR

Saline

Intervention Type OTHER

Negative control

Sodium Lauryl Sulfate (SLS)

Sodium lauryl sulfate to produce mild irritation as a positive control

Group Type ACTIVE_COMPARATOR

SLS

Intervention Type OTHER

Provides a slight irritation for a positive control

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

2% CHG Cloth solution

Investigational CHG

Intervention Type DRUG

Vehicle Cloth

Excipients from CHG cloth only

Intervention Type DEVICE

Active Comparator

Active comparator

Intervention Type DRUG

Saline

Negative control

Intervention Type OTHER

SLS

Provides a slight irritation for a positive control

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Chlorhexidine Gluconate Control DynaHex-2 Sodium Lauryl Sulfate

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Free of skin disorders
* Signed consent

Exclusion Criteria

* Allergies to latex
* Topical or systemic steroids, antihistamines, antiinflammatory agents 7 days prior or during testing
* severe illness
* Pregnant (females)
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medline Industries

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

J Pullman, MD

Role: PRINCIPAL_INVESTIGATOR

BioScience Laboratories

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

BioScience Laboratories

Butte, Montana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R13-051

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.